Reimbursement of pharmaceuticals related to artificial insemination
From 2018, in vitro fertilization (IVF) and embryo transfer services and pharmaceuticals are fully financed by EHIF. Previously, the Ministry of Social Affairs paid for these pharmaceuticals and services. In addition, from 2018, you do not have to apply for reimbursement for IVF pharmaceuticals after you have purchased them.
Women up to the age of 40 (incl.) are entitled to a 100% discount on the pharmaceuticals necessary for in vitro fertilization immediately at a pharmacy when buying them. At the pharmacy, they only have to pay the prescription fee, which is 2.5 euros, and the part exceeding the maximum price of the reimbursable pharmaceutical, provided that the pharmaceutical is more expensive than the reference price listed by EHIF. Ask your doctor for more information about different pharmaceuticals and in vitro fertilization.
The pharmacy offers a 100% discount for pharmaceuticals that contain the following active ingredients:
- follitropin alpha;
- follitropin beta;
- ganirelix;
- goserelin;
- triptorelin;
- cetrorelix;
- lutropin;
- corifollitropin;
- chorionic gonadotropin alpha.
|
Reimbursable medicines |
ATC code |
Active substance |
|---|---|---|
|
PREGNYL inj subst 5000 IU vial 1 ml solvent N1 |
G03GA01 |
chorionic gonadotropin |
|
BEMFOLA 150 IU/0.25 ml solution for injection in a pre-filled pen N1 |
G03GA05 |
follitropin alpha |
|
BEMFOLA 225 IU/0.375ml solution for injection in a pre-filled pen N1 |
G03GA05 |
follitropin alpha |
|
BEMFOLA 300 IU/0.5 ml solution for injection in a pre-filled pen N1 |
G03GA05 |
follitropin alpha |
|
BEMFOLA 450 IU/0.75 ml solution for injection in a pre-filled pen N1 |
G03GA05 |
follitropin alpha |
|
BEMFOLA 75 IU/0.125 ml solution for injection in a pre-filled pen N1 |
G03GA05 |
follitropin alpha |
|
BEMFOLA 300 IU/0.5 ml solution for injection in a pre-filled pen N1 |
G03GA05 |
follitropin alpha |
|
BEMFOLA 450 IU/0.75 ml solution for injection in a pre-filled pen N1 |
G03GA05 |
follitropin alpha |
|
BEMFOLA 900 IU/1.5 ml solution for injection in a pre-filled pen N1 |
G03GA05 |
follitropin alpha |
|
GONAL-F powder and solvent for solution for injection 75 IU N1 |
G03GA05 |
follitropin alpha |
|
OVALEAP 300 IU/0.5 ml solution for injection N1 |
G03GA05 |
follitropin alpha |
|
OVALEAP 450 IU/ 0.75 ml solution for injection N1 |
G03GA05 |
follitropin alpha |
|
OVALEAP 900 IU/1.5 ml solution for injection N1 |
G03GA05 |
follitropin alpha |
|
PUREGON solution for injection 300 IU 0.36 ml N1 |
G03GA06 |
follitropin beta |
|
PUREGON solution for injection 50 IU 0.5 ml N5 |
G03GA06 |
follitropin beta |
|
PUREGON solution for injection 900 IU 1.23 ml N1 |
G03GA06 |
follitropin beta |
|
LUVERIS powder and solvent for solution for injection 75 IU N1 |
G03GA07 |
lutropin alpha |
|
OVITRELLE solution for injection in a pre-filled pen 250mcg/0.5ml N1 |
G03GA08 |
chorionic gonadotropin alpha |
|
ELONVA solution for injection 100mcg/0.5ml N2 |
G03GA09 |
corifollitropin alpha |
|
ELONVA solution for injection 150mcg/0.5ml N1 |
G03GA09 |
corifollitropin alpha |
|
ORGALUTRAN solution for injection 0.25 mg/0.5 ml 0.5 ml N1 |
H01CC01 |
ganirelix |
|
CETROTIDE powder and solvent for solution for injection 0.25 mg N1 |
H01CC02 |
cetrorelix |
|
RESELIGO implant in a pre-filled syringe 10.8 mg N1 |
L02AE03 |
goserelin |
|
RESELIGO implant in a pre-filled syringe 3.6 mg N1 |
L02AE03 |
goserelin |
|
ZOLADEX implant 3.6mg N1 |
L02AE03 |
goserelin |
|
DIPHERELINE 11.25 MG prolonged suspension powder 11.25mg N1 and solvent N1 |
L02AE04 |
triptorelin |
|
DIPHERELINE 3.75 MG prolonged suspension powder 3.75mg N1 and solvent N1 |
L02AE04 |
triptorelin |
*When calculating the benefit, the patient's own contribution of 2.50 euros of the discount prescription is not taken into account.